Real-world evaluation of therapeutic anticoagulation for cancer-associated thromboembolism: A retrospective analysis
Journal of Oncology Pharmacy Practice
Published online on April 02, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundThrombosis is the second leading cause of death in cancer patients and treatment for thrombosis and prevention for secondary prophylaxis is anticoagulation. Low-molecular-weight heparin (LMWH) is more effective than vitamin K antagonists for the ...
BackgroundThrombosis is the second leading cause of death in cancer patients and treatment for thrombosis and prevention for secondary prophylaxis is anticoagulation. Low-molecular-weight heparin (LMWH) is more effective than vitamin K antagonists for the ...